Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Total 13F shares
-
21,786,798
-
Share change
-
-952,263
-
Total reported value
-
$25,053,762
-
Put/Call ratio
-
49%
-
Price per share
-
$1.15
-
Number of holders
-
67
-
Value change
-
-$1,964,114
-
Number of buys
-
24
-
Number of sells
-
45
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q4 2025
As of 31 Dec 2025,
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,786,798 shares.
The largest 10 holders included
CAS Investment Partners, LLC, VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, 683 Capital Management, LLC, KPS Global Asset Management UK Ltd, WORLDLY PARTNERS MANAGEMENT, LLC, BlackRock, Inc., RBF Capital, LLC, JANE STREET GROUP, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.